Cancer Research Institute, a nonprofit organization, has awarded $450,000 to Oncovir, Inc., to Produce and Supply Hiltonol® (Poly-ICLC) for Use in Clinical Trials of Cancer Vaccines and Other Immunotherapies.
On Jan. 19, 2011, a free online counseling service will be available to expecting and breastfeeding moms anywhere in the country through the California Teratogen Information Service (CTIS).
Chances of becoming parents are constantly increasing with options that now include improved embryology laboratory techniques including day-5 blastocyst transfers, single embryo transfers, egg freezing, preimplantation genetic testing (PGD), and egg and sperm donation, all of which will be discussed Jan. 20 at Greenwich Hospital.
As the first major medical center in North Texas to implement electronic medical records in all its clinical practice groups, UT Southwestern Medical Center today applauded the government’s initiative to get hospitals and health care providers across the nation to embrace new health care technology.
Building upon recent laboratory discoveries on resistance by cancer cells to therapies that attempt to starve cancer, scientists at New Jersey’s only NCI Comprehensive Cancer Center are conducting a clinical trial that further explores how to prevent that action. The goal is to discover if an anti-malaria drug is able to block a cellular process that acts as a survival method for malignant cells in human melanoma.
The Mood Disorders Program at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, along with the Bipolar Trials Network, is launching Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness).
Residents of Cuyahoga County, and later Lorain County, will soon have the opportunity to contribute to the establishment of a national resource for childhood growth and development. The National Children’s Study is the largest, long-term study of children’s health ever conducted in the U.S.
United States Drug Testing Laboratories (USDTL) launched two new tests for monitoring long-term alcohol exposure on Friday. Using fingernail and hair specimens, the new assay is the first and only test to report a donor’s alcohol exposure for the past 90 days reliably.
A new study is the first to calculate the financial and social costs of limiting access to trial data — and finds that extending the term of exclusive access will lead to higher drug costs in the short term but also to more than 200 extra drug approvals and to greater life expectancy in the next several decades.
Mayo Clinic is the first in the U.S. to use the first minimally invasive freezing balloon technology for the treatment of atrial fibrillation (AF) approved in December by the U.S. Food and Drug Administration. The first patient received the treatment Tuesday, Jan. 4.
A team of researchers at Mount Sinai School of Medicine has developed the first web-based screening tool for Traumatic Brain Injury (TBI). It is estimated that about seven percent of people in the United States have diagnosed or undiagnosed TBI.
UTHealth and Children's Memorial Hermann Hospital have launched the first Phase I safety study approved by the FDA to investigate the use of a child’s own umbilical cord blood stem cells for pediatric traumatic brain injury.
The Specialty Hospital at Levindale opened Maryland’s first high intensity unit inside a chronic hospital to provide heart monitoring for patients who require specialized medical care and treatment.
Alkeus Pharmaceuticals and Columbia University announced today that they have entered into a license agreement for a set of potential therapies for the treatment of dry age-related macular degeneration (dry-AMD), Stargardt disease, and other degenerative diseases of the eye. Left untreated, these conditions often lead to impaired vision and even blindness.
Clinical trials started in December 2010 to determine how well an anti-obesity compound derived from a Chinese herb works in humans. South Dakota State University researcher Gareth Davies, the scientific director for the Avera Institute for Human Behavioral Genetics in Sioux Falls, said collaborators from SDSU and Avera have published several articles about the compound, which they call AIHBG-10.
Famed chef Frank Stitt has partnered with UAB Hospital's hotel style room service meal program. Stitt has designed three menu items now offered on the hospital's room service meal plan for patients.
As the number of non-English speakers seeking healthcare in the United States continues to grow, so does the need for medical interpreters who can serve as a liaison between patients and their doctors. Dr. Olgierda Furmanek, an associate professor at Wake Forest University has designed a new graduate level curriculum in response to this burgeoning career opportunity.
Metro Denver residents can now notify Porter or Littleton hospitals that a patient is on the way to the ER and provide information about the patient and the healthcare needed.
David H. Adams, MD, Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Samin K. Sharma, MD, the Zena and Michael A. Weiner Professor and Director of the Cardiac Catheterization Laboratory, and Annapoorna S. Kini, MD, Associate Professor and Associate Director of the Cardiac Catheterization Laboratory at The Mount Sinai Medical Center, have performed the first implantation of the Medtronic CoreValve® Transcatheter Aortic Valve Prosthesis in the United States.
Surgeons at the University of Illinois Medical Center at Chicago are the first to offer robotic kidney transplantation to morbidly obese patients and report fewer complications among this high risk population.
With the publication of the nation's first comprehensive, federally funded guide to hospital emergency preparedness exercise development, Dr. Nathaniel Hupert at Weill Cornell Medical College and his collaborators have provided a new toolset for strengthening hospitals' ability to protect communities nationwide against public health disasters, such as creating care centers during an influenza pandemic or treating casualties in the wake of a bioterrorism attack.
New spinoff company forms out of research done at Roswell Park Cancer Institute; Buffalo-based company will develop photosensitizing compounds used in photodynamic therapy.
Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.
Awarding-winning public service program on BECON TV aims to promote the community’s overall health and quality of life
In four years, UMHS has saved more than $15 million on the cost of Medicare patients' care, while also improving the quality of care that Medicare patients receive at U-M hospitals and clinics. Those achievements come from participation in the Medicare Physician Group Practice Demonstration Project.
With the goal of developing new, more effective and personalized cancer treatments, Horizon Discovery, based in Cambridge, England, has secured from Case Western Reserve University exclusive rights to a panel of new human isogenic cell models.
Doctors at UT Southwestern Medical Center and the Institute for Exercise and Environmental Medicine are recruiting participants for a study of the effects of weight loss on obese women with shortness of breath.
Americans fear the quality of their healthcare is at risk, according to the Vital Health Report, a survey released today by the American Society of Anesthesiologists (ASA).
The Department of Thoracic Surgery at Geisinger Medical Center (GMC) recently performed its first transcervical thymectomy, joining other major academic medical centers nationwide that perform the minimally invasive surgical procedure.
In a sustained effort to seek consensus-driven, patient-centered priorities that would build a high-value health care system, the Mayo Clinic Health Policy Center hosted a symposium Dec. 5–7 entitled “Achieving the Vision: Advancing High-Value Health Care,” which featured patients, providers, payers and national policy experts.
The long-term performance of medical implant devices, like heart valves and cardiac stents, could be enhanced substantially by new bio-coating technology recently licensed to University of Alabama at Birmingham spin-out company Endomimetics LLC through the UAB Research Foundation.
Nearly a quarter of Americans live in rural areas, which consistently report higher cancer mortality rates than urban and suburban areas. Among the complex causes for this disparity is that only 10 percent of physicians practice in rural areas and almost 4 out of 10 rural residents live at least an hour from an urban area. Finding the time, transportation, and financial resources for travel to urban academic medical centers, the standard bearers for quality cancer care, often proves difficult. Most rural residents have their cancer treated in their communities, although a survey suggests rural physicians are less likely to attend national medical conferences and may have difficulty keeping up with important oncology literature.
A groundbreaking, first in humans vaccine will be tested in an early phase clinical trial that will soon begin at Wake Forest University Baptist Medical Center. Eighteen patients will be the first in the world to receive it.
2011 REYATAZ® (atazanavir sulfate) “Fight HIV Your Way” Contest call for entries begins on December 1, 2010.
Hospital for Special Surgery is announcing the creation of a new research center and its selection by the U.S. Food and Drug Administration to develop an International Consortium of Orthopedic Registries. The consortium will serve as a model for other medical device registries.
Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effective treatments.
The new era of Weight Watchers is here. Today Weight Watchers, the world-renowned leader in weight management, has announced it is introducing in the United States a successor to its popular POINTS weight loss system – the new PointsPlus program.
A recent listing* of Philadelphia adult kidney transplant programs by The Scientific Registry of Transplant Recipients (SRTR) has listed the transplant program at Thomas Jefferson University Hospital as having the shortest wait times for patients seeking a transplant among programs that have a three-year survival rate of greater than 90 percent.
HealthGrades, the nation’s leading independent ratings organization, today made available to organ transplant patients a list of those hospitals with the best track record for survival and chances of receiving a donor organ. HealthGrades annual evaluation of the nation’s top-performing hospitals in organ transplantation includes clinical quality data, based on patient outcomes, for each of the 210 adult acute care hospitals that perform transplants.
In time for this year’s Great American Smokeout, St. Jude Children’s Research Hospital expands its smoking cessation efforts by offering free counseling and nicotine replacement therapy to survivors of childhood or adult-onset cancer.
Global Health Informatics Partnership (GHIP) has actively gained the support and participation of numerous international health-related organizations as it seeds and grows a collaborative learning community focused on the creation of a collaborative network and clearinghouse of information for global health informatics.
School of Pharmacy professor Bruce Stuart says good medication management procedures--a key to effective care coordination—will allow pharmacists to play a major role in health care reform.
The Porter Breast Center and Porter Comprehensive Breast Care have received the “gold standard” in accreditation for breast centers nationally. After a recent survey, the National Accreditation Program for Breast Centers (NAPBC), which is administered by the American College of Surgeons, granted three-year full accreditation designation to Porter’s Breast program.
New quality initiative to improve the care of patients with vascular disease.
As Rose Pharmaceuticals marks its first anniversary this month, the stockbroker and University at Buffalo researchers who founded the company are celebrating a year of accomplishments.
Gone are the days when a doctor’s only way of helping patients is by treating the disease after symptoms have started. Instead, a new approach to medicine, called “Desktop Medicine” is emerging, in which the emphasis shifts from diagnosing diseases and treating symptoms to identifying risk-factors for medical conditions such as hypertension and osteoporosis, and intervening before they develop. The commentary appears in the current issue of the Journal of the American Medical Association.
Commitment from Johnson & Johnson Enables Growth of Nation’s Largest Mobile Health Initiative.
Being diagnosed with cancer is tough enough, but many times cancer patients have to endure hours of chemotherapy to treat the disease. A new program at a cancer hospital in Boston may just be what the doctor ordered to help patients pass the time.
Neurological researchers at Rush University Medical Center are part of a multicenter, National Institutes of Health (NIH) study to determine the levels of stroke risk and stroke recurrence in patients with narrowed brain arteries.
AMIA, the association for informatics professionals, has been selected to serve as a partner for one year in the National Priorities Partnership (NPP), beginning Sept. 21, 2010. The NPP works to target ways to eliminate harm, waste, and disparities in health care delivery.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right